<DOC>
	<DOCNO>NCT03023371</DOCNO>
	<brief_summary>The aim study establish nation-wide cohort study IgG4-related disease ( IgG4-RD ) China . Methods : All patient fulfil diagnostic criterion IgG4-RD ( 2011 ) would enrol multi-centers around China . A online database system establish . Endpoints : The primary endpoint investigate clinical manifestation Chinese IgG4-RD patient ; secondary endpoint include demographic feature , laboratory characteristic , immunological test , image pathological feature , addition , treatment prognosis disease .</brief_summary>
	<brief_title>National Registry IgG4-RD China</brief_title>
	<detailed_description>This multicenter registry study IgG4-RD patient . Newly diagnose IgG4-RD patient recruit allover China . Inclusion criterion : patient definite , probable , possible IgG4-RD accord 2011 comprehensive diagnostic criterion IgG4-RD recruit . Exclusion criterion : patient malignancy autoimmune disease exclude . The data upload platform Chinese Rheumatology Information Platform . Demographic data , initial symptom , disease duration , history allergy , physical examination , organ involvement , laboratory finding , radiological pathological result , well treatment , side effect record . This study approve Medical Ethics Committee PUMCH ( Beijing , China ) . All patient signe informed consent . Statistical Analysis : All parameter describe standard summary statistic , include mean , standard deviation , minimum , maximum . All statistical analysis perform SPSS . Endpoints : The primary endpoint investigate organ involvement Chinese IgG4-RD patient . The secondary endpoint include demographic feature , laboratory characteristic , immunological test , image pathological feature , addition , treatment prognosis disease .</detailed_description>
	<criteria>Conforming diagnostic criterion IgG4RD ( 2011 ) ; Excluding mimic IgG4RD , include tumor , vasculitis sarcoidosis .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Registry ; cohort study ; IgG4-related disease</keyword>
</DOC>